Herantis Pharma Oyj

HRPMFOTCHealthcare

$3.51

+$0.00(+0.00%)

Market Cap$59465016

P/E Ratio—

52W High$3.51

52W Low$3.51

Avg Volume0

Open$3.51

Beta0.43

Overview

Herantis Pharma Oyj (HRPMF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

HRPMF · earnings · updated Jun 9, 2026

No earnings history available.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q1 FY2023	Mar 2, 2023	—	—	—	—	—	—
◌ Q3 FY2022	Aug 25, 2022	—	—	—	—	—	—
◌ Q1 FY2022	Mar 7, 2022	—	—	—	—	—	—
◌ Q3 FY2021	Aug 26, 2021	—	—	—	—	—	—
◌ Q1 FY2021	Mar 3, 2021	—	—	—	—	—	—
◌ Q3 FY2020	Aug 25, 2020	—	—	—	—	—	—
◌ Q1 FY2020	Feb 27, 2020	—	—	—	—	—	—
◌ Q3 FY2019	Aug 28, 2019	—	—	—	—	—	—

Q1 FY2023

Mar 2, 2023

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2022

Aug 25, 2022

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2022

Mar 7, 2022

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2021

Aug 26, 2021

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2021

Mar 3, 2021

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2020

Aug 25, 2020

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2020

Feb 27, 2020

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2019

Aug 28, 2019

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

No analyst estimates available for HRPMF.

About Earnings & Data Methodology

Herantis Pharma Oyj (HRPMF) reports earnings quarterly as a OTC-listed Biotechnology company. The next HRPMF earnings date is expected around September 1, 2026.

Each quarter, investors track HRPMF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HRPMF revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

HRPMF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

HRPMF earnings · 3 questions

Herantis Pharma Oyj's next earnings report is expected around September 1, 2026. HRPMF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HRPMF historically reports after market close (AMC).

HRPMF earnings datewhen is HRPMF earningsHRPMF next earnings datewhen does HRPMF report earningsHRPMF earnings calendar

▸ Source: FMP · Herantis Pharma Oyj SEC filings · US GAAP · Herantis Pharma Oyj SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026